More U.S. consumers have sought out Coenzyme Q10 supplements in the last two years, motivated by publicity about the cardiovascular health benefits of taking the substance, as well as research showing that statin drugs reduce CoQ10 levels in the body, and that high doses of CoQ10 can help Parkinson’s disease sufferers.
But the positive impacts on industry revenues have been blunted by an acute supply shortage that forced several ingredient suppliers out of the CoQ10 business and caus
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.